5 completed. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Hematologic Malignancies: new trials by email Literature Review of Hematologic Malignancies trials Research Report on Hematologic Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma Denosumab, Zoledronic acid, Placebo to Denosumab - Cancer, Hematologic Malignancies | Phase 3 | Completed | Amgen | 1718 | 2012-05-17 | 2022-11-08 |
| Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation Red blood cell Transfusion - Hematologic Malignancies | Phase 3 | Completed | Ottawa Hospital Research Institute | 300 | 2011-03-01 | 2016-10-12 |
| Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) Posaconazole, ABLC - Invasive Fungal Infections, Hematologic Malignancies | Phase 3 | Completed | M.D. Anderson Cancer Center | 46 | 2008-06-01 | 2016-09-29 |
| Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy StemEx® - Hematologic Malignancies, Acute Myeloid Leukemia | Phase 2 / Phase 3 | Completed | Gamida Cell -Teva Joint Venture Ltd. | 101 | 2007-10-01 | 2015-07-10 |
| Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation Empirical Vancomycin, Prophylactic Vancomycin - Streptococcal Sepsis, Hematologic Malignancies | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 126 | 2003-11-01 | 2006-09-08 |
Hematologic Neoplasms (5) · Blood Protein Disorders (1) · Bone Diseases (1) · Bone Marrow Diseases (1) · Bone Neoplasms (1) · Fractures, Bone (1) · Hematologic Diseases (1) · Hodgkin Disease (1) · Invasive Fungal Infections (1) · Leukemia, Lymphoid (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1)
Hemic and Lymphatic Diseases (5) · Neoplasms by Site (5) · Hematologic Diseases (4) · Neoplasms (4) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bacterial Infections and Mycoses (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Chronic Disease (1)
Amphotericin B (1) · Denosumab (1) · Erythrocyte Transfusion (1) · Zoledronic Acid (1) · posaconazole (1)
Amgen (1) · Gamida Cell -Teva Joint Venture Ltd. (1) · M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · Ottawa Hospital Research Institute (1)
United States (4) · Canada (2) · Hungary (2) · Italy (2) · Spain (2) · Australia (1) · Austria (1) · Bulgaria (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · Ireland (1) · Israel (1)
Agha Mounzer, MD (1) · Alberto Bosi, MD (1) · Celia Grosskreutz, MD (1) · Christelle Ferra, MD (1) · Cristina Arbona, MD (1) · Dr. Cristina Diaz de Heredia, MD (1) · Dr. Mi Kwon, MD (1) · Dr. Pere Barba, MD (1) · Entezam Sahovic, MD (1) · Guillermo Sanz, MD (1) · Igor B. Resnick, MD, PhD (1) · Issam Raad, MD/Professor (1) · Jason Tay, MD FRCPC MSc (1) · Jorge Sierra, MD (1) · Ka Wah Chan, MD (1)
PMID 22814329, PMID 29477778, PMID 32083994, PMID 34932836, PMID 41114449